Indeed, in a HER2/Neu transgenic mouse model of breast cancer, a disruption of type I interferon signaling results in early onset of breast cancer, which exhibits an increased number of breast CSCs with an enhanced clonogenic activity and expression of stemness markers [64]. Here, ERBB2 is linked to breast cancer.